[go: up one dir, main page]

EP2789313A2 - Dispositif d'introduction, notamment cathéter, pour l'introduction d'un implant hybride médical et implant hybride médical destiné à être introduit à l'aide d'un dispositif d'introduction - Google Patents

Dispositif d'introduction, notamment cathéter, pour l'introduction d'un implant hybride médical et implant hybride médical destiné à être introduit à l'aide d'un dispositif d'introduction Download PDF

Info

Publication number
EP2789313A2
EP2789313A2 EP14158463.1A EP14158463A EP2789313A2 EP 2789313 A2 EP2789313 A2 EP 2789313A2 EP 14158463 A EP14158463 A EP 14158463A EP 2789313 A2 EP2789313 A2 EP 2789313A2
Authority
EP
European Patent Office
Prior art keywords
implant
partial
expanding
self
insertion element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14158463.1A
Other languages
German (de)
English (en)
Other versions
EP2789313A3 (fr
Inventor
Amir Fargahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotronik AG
Original Assignee
Biotronik AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotronik AG filed Critical Biotronik AG
Publication of EP2789313A2 publication Critical patent/EP2789313A2/fr
Publication of EP2789313A3 publication Critical patent/EP2789313A3/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/243—Deployment by mechanical expansion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/243—Deployment by mechanical expansion
    • A61F2/2433—Deployment by mechanical expansion using balloon catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436—Deployment by retracting a sheath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958—Inflatable balloons for placing stents or stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/852—Two or more distinct overlapping stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/826—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0048—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular

Definitions

  • the invention relates to an introducer, in particular a catheter, for introducing a medical hybrid implant for implantation in an animal and / or human body and a hybrid implant for insertion with an introducer and a method for introducing the medical hybrid implant using the introducer according to the preambles of independent claims.
  • valve implants In medicine implants are often used, which are introduced permanently or at least for a longer period of time in an animal and / or human body to fulfill replacement functions. These include, for example, pacemakers, pacemakers for Parkinson's patients, cardiac implants, cochlear implants, retinal implants, dental implants, implants for joint replacement, vascular prostheses or stents.
  • valve implants such as aortic valve implants, which take over the function of the natural aortic valve are known in the field of cardiac implants. In this case, the valve implant is fixed immediately after implantation after expansion of the implant structure and assumes the position of the natural aortic valve.
  • Implants are connected to catheters prior to insertion into the body and must be secured in such a way that they can be released and defined in a defined manner by the catheter without complications.
  • a common problem in this case is that the implant is fixed with a malposition, resulting in a failure of the implant can lead. This often occurs, for example, in calcification, ie the deposition of calcium salts, in particular calcium phosphate (hydroxyapatite) on the structures of the heart and especially in strongly asymmetrically calcified aortic stenosis.
  • calcification ie the deposition of calcium salts, in particular calcium phosphate (hydroxyapatite) on the structures of the heart and especially in strongly asymmetrically calcified aortic stenosis.
  • hybrid implants can be used, which have two individual implants, which have different tasks.
  • the invention has for its object to provide an introducer, with the high-precision and targeted release of a hybrid implant can be done.
  • Another object is to provide a corresponding medical hybrid implant which can be implanted accurately and reliably at an implantation site.
  • Yet another object can be seen therein to provide a method for introducing the medical hybrid implant according to the invention by means of the insertion device according to the invention, in which the insertion and release of the medical hybrid implant, can be done quickly, reliably and without complications.
  • a proposed insertion device for introducing a medical hybrid implant wherein the hybrid implant has at least two partial implants, of which at least a first partial implant is externally expandable and at least one second partial implant is self-expanding, comprising a first insertion element, which has at least one expansion aid for expanding the at least first implant includes a foreign expandable partial implant, and a second Insertion element and at least a third insertion element for releasing the at least second self-expanding partial implant, wherein the at least first externally expandable partial implant with the expansion aid is expandable and the at least second self-expanding partial implant is releasable by a relative movement between the second and the at least third insertion element, wherein the first insertion element displaceable is disposed within the at least second insertion element.
  • the embodiment according to the invention makes it possible to provide an introduction device, for example a catheter, with which the hybrid implant can be positioned particularly quickly and reliably.
  • a secure anchoring of the hybrid implant at the implantation site such as an annulus, can be provided.
  • a compact system can be used, since a radial mounting of the components of the insertion device is possible and thereby a length of the insertion device can be shortened compared to systems of the prior art.
  • the hybrid implant also has a shorter length compared to implants of the prior art. It has been shown that thereby a need for an additional stabilizing auxiliary apparatus at the implantation area, such as a cardiac pacemaker, can be reduced or particularly advantageously dispensed with.
  • advantages of systems with externally expandable and self-expanding implants can be combined in one introducer. This would be eg a good adaptability of the self-expanding partial implant to a patient anatomy at the implantation site, such as an annulus of a native heart valve. Likewise, a stable attachment using the externally expandable partial implant at the implantation site would be possible.
  • Conventional self-expanding implants often require the use of a large amount of material, such as nitinol, to ensure adequate stability.
  • a hybrid implant according to the invention a quantity of metal could be reduced compared with implants of the prior art, which is particularly patient-friendly.
  • Advantageous different expansion mechanisms are applied, resulting in a particularly versatile hybrid implant.
  • a repositioning of the partially released hybrid implant can be made possible.
  • the self-expanding partial implant has only a small radial force, which can be overcome again with little effort in a so-called "resheathing".
  • a functional test of the hybrid implant and, in the event of a defect, a removal of the malfunctioning hybrid implant can take place.
  • an expanding agent or balloon is already in the body for expanding. This reduces the strain on the patient and shortens the time of the procedure. Since the second insertion element is arranged to be axially displaceable with respect to the at least third insertion element, the self-expanding partial implant can remain securely fixed axially on the third insertion element despite the free movement of the second insertion element.
  • a hybrid implant should be understood to mean an implant comprising at least two partial implants, the partial implants being spatially and / or functionally independent of each other.
  • the hybrid implant is composed of at least two separate components / partial implants.
  • a partial implant represents a component that functions independently and / or can be used (for a general definition of implant, reference is made to the comments below).
  • externally expandable on the other hand, it is intended here to be “passively expandable” and / or that the partial implant is non-self-extant and / or expandable or plastically deformable by means of a force supplied from the outside.
  • Structurally simple passive expansion can be done by means of an expansion aid, such as a mechanical, pneumatic and / or hydraulic spreader or advantageously a balloon.
  • an expansion aid such as a mechanical, pneumatic and / or hydraulic spreader or advantageously a balloon.
  • self-expanding is here “actively expandable” and / or that the partial implant independently or automatically, so expanded or expandable without outside help is understood.
  • the phrase “slidably disposed within the at least second insertion element” is to be understood to mean that the first Insertion element is arranged in a lumen of the second insertion element and relative to this, in particular in the axial direction, can be moved.
  • a direction from a proximal end of the insertion direction to a distal end of the insertion device and / or vice versa should be understood.
  • the first externally expandable partial implant is preferably crimped onto the expansion aid.
  • the second self-expanding partial implant preferably rests on a radial inner wall of the second insertion element, whereby the second insertion element acts as a clamping body for the self-expanding partial implant.
  • a "clamping body” is to be understood as meaning a body which, by means of a clamping action and / or a frictional connection, holds another element, in particular the partial implant, in the insertion device in a fixed position.
  • the self-expanding partial implant is thus held captive in a clamping state in the insertion device. In the clamping state, an interaction between an expansion force of the partial implant and a clamping force of the second insertion element of the former holds in position, whereby a slipping of the implant from the insertion device or the clamping body is prevented.
  • a spatially comfortable fixation of the self-expanding partial implant can be provided if this is fixed in a protective cover of the second insertion element.
  • This protective cover has a larger radial diameter than the second insertion element and constitutes a functional part of the second insertion element, ie it can be moved together with it.
  • the protective cover is captively connected to the second insertion element.
  • any type of connection considered useful to a person skilled in the art such as a force, a form or a material bond, for example by means of welding, soldering, screwing, nailing or gluing, can be considered for both attachment variants.
  • properties such as size, material, coating, friction, etc., can be tailored to the requirements of the component.
  • the protective cover can also be embodied in one piece with the second insertion element, it being understood in one piece that the protective cover and the second insertion element are formed by the same component and / or a cast and / or can be separated from each other only with loss of function of at least one of the components.
  • the at least third insertion element is arranged radially between the first insertion element and the second insertion element.
  • a further function of the insertion device can be realized. This is done, for example, by the at least third insertion element being designed to hold it in position at least during an expansion of the second self-expanding partial implant. This can take place by means of any principle which the person skilled in the art considers applicable, such as, for example, a force and / or positive connection, static friction or the like.
  • a distal end region of the at least third insertion element may be embodied as an implant holder having at least one structure, such as a hook, eyelets, slots, etc., which is designed to interact with a contact structure of the partial implant.
  • implant holder having at least one structure, such as a hook, eyelets, slots, etc., which is designed to interact with a contact structure of the partial implant.
  • eyelets which are arranged in the assembled state of the partial implant in the insertion device at the end of the partial implant facing the proximal end of the introducer.
  • the insertion device may comprise at least a fourth insertion element, which is arranged radially within the first insertion element, whereby a function can be integrated again.
  • the expression "arranged radially inside the first insertion element” is to be understood to mean that the at least fourth insertion element is arranged in a lumen of the first insertion element. "In addition, it can be arranged displaceably within the second insertion element or it can be relative to it, in particular
  • the at least fourth insertion element is designed, for example, to receive a guide element such as, for example, an insertion wire and / or a so-called "guide wire.” In this way, delivery to the implantation site can be effected safely and structurally simply End of the guide element is preferably arranged a catheter tip.
  • the first introducer may be referred to as an outer shaft (hereinafter also referred to as a balloon outer shaft) and the fourth introducer as an inner shaft (hereinafter also referred to as a balloon inner shaft) of a balloon catheter and the second introducer as an outer shaft (hereinafter also referred to as a catheter outer shaft ) and the third insertion element as an inner shaft (hereinafter also referred to as the catheter inner shaft) of a catheter with which a self-expanding implant can be supplied and implanted understood.
  • the introducer is a four-shaft catheter system with at least these components. Considering a radially outermost sheath or stabilizer tube, the introducer may be considered a five-sheath catheter system.
  • the first insertion element is inseparably connected to the at least fourth insertion element, whereby they can be moved captive together. If the first insertion element is arranged so as to be axially displaceable with respect to the at least third insertion element, positioning of the expansion aid with the externally expandable partial implant relative to the self-expanding partial implant can be done in a structurally simple manner.
  • the definition of axial is analogous to the definition of axial direction.
  • An axial movement range for the expansion aid can be advantageously provided when the second insertion element is arranged with respect to the at least first insertion element.
  • a relative position of the insertion device at the implantation remains unaffected by the exposure movement of the second insertion, when the second insertion element is arranged axially displaceable with respect to the at least fourth insertion element.
  • a relative position of the introducer at the implantation site, probed by the guide member with the catheter tip, can be securely held.
  • the movements can be conveyed in a structurally simple manner if the first insertion element and / or the second insertion element and / or the third insertion element and / or the at least fourth insertion element each have at least one grip segment.
  • the grip segment of the first and the fourth insertion element is in each case designed to, in at least one operating state, the first and the at least fourth Insertion to move independently of the second and the at least third insertion. Since these grip segments are permanently connected to each other, both insertion elements can be operated with two handle segments.
  • the operating state may here preferably represent the positioning of the expansion aid.
  • the handle segment of the second insertion element is designed to move the second insertion element independently of each of the first, the at least third and the at least fourth insertion element in at least one operating state.
  • the operating state represents in particular the exposure of the second self-expanding partial implant. If movement of the insertion elements relative to one another is undesirable, the respective relevant insertion elements and / or their grip segments can be releasably connected to one another.
  • Each handle segment is preferably located at the proximal end of the introducer or at a portion of each introducer located outside the body during implantation.
  • the grip segment can be formed by a housing part of an insertion element and / or a separate component arranged or formed on the insertion element.
  • a good operability and a structurally favorable structure are given when the handle segment of the radially inner insertion element (balloon inner shaft) in the direction of the proximal end and / or at the proximal end of the insertion device and the handle segment of the most radially outer insertion element (catheter outer shaft) is arranged in the direction of the distal end of the insertion device.
  • the other two gripping segments are each axially in between, the handle segment of the balloon outer shaft more in the direction of the proximal end and the handle segment of the catheter inner shaft more in the direction of the distal end.
  • the at least third insertion element has a stop, which limits a relative movement of the second insertion element with respect to the at least third insertion element.
  • a degree of movement of the second insertion element and thus the exposure of the self-expanding partial implant can be intuitively monitored and / or restricted structurally simple and intuitive for an operator. Consequently, this is one gradual release of self-expanding partial implant easily executable.
  • the stop can here be formed by any person skilled in the art for implementable means, such as a (colored) mark, a groove, a stop, etc.
  • the introducer also has a sheath or a stabilizing tube, which in the circumferential direction around the radially outermost insertion and / or the second insertion element extends.
  • the shaft sheath or the stabilization tube has a grip segment in the direction of its proximal end. This grip segment is arranged more distally than the most distally arranged grip segment of the insertion elements, ie the catheter outer shaft.
  • the stabilization tube and / or its handle segment must / must be fixed during the implantation of the hybrid implant and in particular during the movement or retraction of the second insertion element in his / her position (s).
  • the insertion device according to the invention can be used in a convenient manner when, in the installed state of the hybrid implant, the at least first externally expandable partial implant faces the distal end of the insertion device and / or the at least second self-expanding partial implant faces away from the distal end of the insertion device.
  • the externally expandable partial implant is located distally of the self-expanding partial implant.
  • the assembled state represents the state in which both partial implants are attached to / in the introducer and this is ready for implantation of the hybrid implant.
  • the externally expandable partial implant was assembled or crimped onto the expansion aid in a fabrication of the introducer.
  • self-expanding partial implant is preferably loaded into the introduction device only in the preparation laboratory. This can ensure that the flap insert is mounted as soon as possible for implantation.
  • the first foreign-expandable partial implant For entry of the first foreign-expandable partial implant into the interaction region of the self-expanding partial implant, the first foreign-expandable partial implant likewise has at least one interaction region for interacting with the at least second self-expanding partial implant, as a result of which an interaction of the two partial implants can take place particularly reliably.
  • the at least second self-expanding partial implant comprises at least one valve insert, whereby the hybrid implant can perform a replacement function, in particular as a check valve, in the body.
  • a hybrid implant that is particularly well matched to its replacement function can be provided if the at least one interaction region of the first externally expandable partial implant can be arranged distally from a valve plane of the valve insert as a result of relative movement between the first insertion element and the second insertion element of the insertion device.
  • the medical hybrid implant has at least two partial implants, of which at least one first partial implant is externally expandable and at least one second partial implant self-expanding, wherein at least one interaction region of the first externally expandable partial implant has an outer diameter and at least one interaction region of the at least second expanded implant self-expanding partial implant in the expanded state have an inner diameter, wherein a dimension of the outer diameter of the at least one interaction region of the first foreign expandable partial implant to a dimension of the inner diameter of the at least one interaction region of at least at least one of the interaction region of the first foreign-expandable partial implant can enter the at least one interaction region of the at least second self-expanding partial implant and the interaction region of the second self-expanding partial implant in the expanded one during a relative movement between a first insertion element and a second insertion element of the insertion State can be fastened by means of
  • the embodiment according to the invention makes it possible to provide a medical hybrid implant which can be positioned particularly quickly and reliably and can be firmly anchored at the implantation site. Furthermore, it can advantageously be adapted to the parameters or anatomical conditions of the implantation site, such as a calcification of a blood vessel wall and / or an annulus, and / or another, congenital and / or pathological anomaly of the implantation site. Furthermore, the hybrid implant has a shorter length compared to implants of the prior art. In addition, small French sizes, for example, between 9 F and 15F, can be realized. Furthermore, different expansion mechanisms can advantageously be used with the two unequally expandable partial implants, resulting in a particularly versatile hybrid implant. This allows advantages of both expansion mechanisms in one implant to be combined.
  • an "implant” should be understood to mean in particular a body which fulfills at least one replacement function permanently or for a longer period of time when implanted in an animal and / or human body.
  • All medical implants that appear appropriate to the person skilled in the art, such as, for example, a heart implant, a cochlear implant, a vascular prosthesis, an appendiceal prosthesis or, particularly advantageously, a design of the medical hybrid implant may be proposed as a valve implant.
  • a "valve implant” is to be understood in particular as meaning a body which fulfills at least one replacement function of a non-return valve, permanently or for a longer period of time during implantation. All medical valve implants that appear appropriate to the person skilled in the art, such as, for example, an aortic valve, a pulmonary valve, a mitral valve or a tricuspid valve implant, would be conceivable here.
  • a design of the medical hybrid implant as a stent in particular a coronary stent, proposed with a / with the stent reversibly or irreversibly connected implant structure and / or valve insert.
  • a "valve insert” should be understood to mean, in particular, an aortic valve, a pulmonary valve, a mitral valve, a tricuspid valve or a venous valve made of natural and / or artificial material.
  • an embodiment of the medical hybrid implant as an aortic valve whereby a sophisticated replacement structure for the most frequently malfunctioning heart valve can be provided. Also, complications such as Disturbances of the mitral valve or a need for a pacemaker can be beneficially reduced.
  • an embodiment as a pulmonary valve or an embodiment as a mitral valve is conceivable.
  • any other implant structure that would appear meaningful to a person skilled in the art would be conceivable.
  • the hybrid implant as a stent, a structurally simple implantable structure can be provided.
  • the first externally expandable partial implant comprises at least cobalt and / or chromium, preferably in the form of stainless steel or medical grade stainless steel and / or a Cr-Ni-Fe steel - here preferably the alloy 316L - or a Co-Cr steel.
  • the second self-expanding partial implant is preferably made of an elastic or superelastic material, such as a metallic material and / or a combination of several metallic materials, such as iron, magnesium, nickel, tungsten, titanium, zirconium, niobium, tantalum, zinc, Silicon, lithium, sodium, potassium, calcium, manganese and / or any other material that appears appropriate to one skilled in the art.
  • the second self-expanding partial implant is made of a shape-memory material, such as a copper-zinc-aluminum alloy and / or nickel-titanium alloy, preferably nitinol.
  • the medical hybrid implant can have a separating means which separates the material of the first externally expandable partial implant from the material of the second self-expanding partial implant or their interaction areas.
  • a "release agent” is to be understood in particular to mean any agent that appears appropriate for the person skilled in the art, such as a spacer and / or in particular a coating. In this case, however, a function transfer, in particular from the externally expandable partial implant to the self-expanding partial implant, must be ensured.
  • a “coating” is to be understood as meaning at least partial and preferably complete encasing of the interaction areas or their struts or stent struts.
  • the coating is formed by an amorphous silicon carbide.
  • any other coating which appears to be suitable for a person skilled in the art would be conceivable which effectively prevents contacting of the materials of the two partial implants and in particular of the metallic materials, in particular NiTi or CoCr, in the presence of electrolytes.
  • the coating can be structurally simple and space-saving a contact problem of different noble metals of the two areas can be solved.
  • the at least second self-expanding partial implant comprises at least one valve insert, whereby the hybrid implant has a replacement function, especially as a check valve, can take over in the body. Since the self-expanding partial implant can adapt flexibly to the anatomy of the patient, the flap insert can thus be adapted advantageously to the circumstances.
  • the flap insert can be connected to any self-expanding partial implant by means of any type of connection deemed useful to the person skilled in the art, such as, for example, sewing and / or gluing.
  • the valve material may be of artificial or natural origin (beef, pork, horse).
  • the flap of the flap insert is made of cattle or pig pericardium.
  • a hybrid implant that is particularly well matched to its replacement function can be provided if the at least one interaction region of the first externally expandable partial implant can be arranged distally from the valve plane of the valve insert as a result of the relative movement between the first insertion element and the second insertion element of the insertion device.
  • a stable attachment of the hybrid implant can be made at the implantation site without damaging the valve insert and / or impairing its function.
  • the externally expandable partial implant is disposed in the intended final state in the flow direction of the flow medium axially in front of the annulus. This can also be prevented that it comes in the Aortenbulbus by the externally expandable partial implant to cover the coronary arteries.
  • the hybrid implant is particularly well adapted to the anatomy of the heart or of a heart valve region.
  • a "flow direction of a flow medium” is to be understood here in particular as the scientifically known flow direction of arterial and / or venous blood in the heart, and particularly advantageously in the case of the aortic valve, the flow of blood from the left ventricle into the aorta.
  • the annulus is preferably the aortic annulus.
  • the at least second self-expanding partial implant has a number of cells.
  • These cells may have any shape that appears appropriate to the person skilled in the art, such as round, oval, triangular, rectangular and / or diamond-shaped. This shape is particularly adapted to be foldable be.
  • the cells are designed substantially diamond-shaped.
  • the term "essentially diamond-shaped" is to be understood here as meaning that forms that are similar to a rhombus or a rhombus, such as a diamond-like shape with rounded corners and / or concave and / or convex sides under the term "diamond-shaped" to be understood.
  • the cells represent the basic structure of the partial implant.
  • a "basic framework” is to be understood in particular as meaning a structure, such as a wire mesh, which essentially specifies a shape and / or a shape of the partial implant.
  • the number of cells is selected such that the second self-expanding partial implant has a low radial force, thereby allowing resheathing with minimal effort.
  • the at least one first externally expandable partial implant comprises at least one sealing structure which is designed to reduce leakage in the implanted state.
  • the sealing structure can promote ingrowth of the hybrid implant.
  • the sealing structure can be formed for example by a so-called "textile skirt" which is arranged on a part of the externally expandable partial implant and in particular on a part which points to the valve insert in the implanted state of the hybrid implant and / or the interaction region of the externally expandable partial implant.
  • the sealing structure may for example be made of a polyester, such as Dacron®.
  • the leakage may be, for example, a valvular and / or a paravalvular leakage.
  • Both partial implants may have at least one anchoring means, whereby the hybrid implant can additionally be attached to the implantation site.
  • an “anchoring means” should be understood to mean, in particular, a loop, a hook, a point and / or another means considered to be suitable for the person skilled in the art.
  • the anchoring means can be designed to be movable independently of the two partial implants, with "movable” here in particular radially movable and particularly advantageous radially movable in the direction of a wall of a blood vessel, such as an aortic wall, while the self-expansion and / or expansion means of the expansion aid, should be understood.
  • an anchoring means can thus advantageously be used to set a variable outer contour of the hybrid implant in the implanted state.
  • a good anchorage can be provided with advantageously low expenditure of force by the self-expansion or the expansion with the expansion aid.
  • a deposit-inhibiting, in particular calcification-inhibiting, coating can be provided on the implant, in particular homocysteic acid.
  • the risk of a malfunction or a functional failure of the hybrid implant can be further reduced.
  • a method for introducing a medical hybrid implant by means of an insertion device comprises at least the following steps: partially expanding a first subregion of an at least second self-expanding subimplant, in particular in the state mounted on the insertion device of the at least second self-expanding subimplant of a distal end region of the at least second self-expanding subimplant; Expanding a complete at least first foreign expandable partial implant; Partial expansion of a second subregion of the at least second self-expanding partial implant, in particular in the state mounted on the insertion device of the at least second self-expanding partial implant of a proximal end region of the at least second self-expanding partial implant.
  • the hybrid implant can be particularly quickly and reliably positioned, anchored and implanted. Furthermore, different expansion mechanisms can advantageously be used with the two unequally expandable partial implants, resulting in a particularly versatile method. This can benefit both Expansion mechanisms are combined in one procedure. Particularly advantageously, a hybrid implant connected to the insertion device by means of the method according to the invention and already partially released can be repositioned in a user-friendly manner. In addition, a functional test can be carried out on a hybrid implant fixed in this way, and this can be removed in the event of a defect.
  • a further advantage is that in the event of a need for post-dilatation of the implantation site and / or an afferent vessel, such as an artery or vein, this can be done simply because the expansion agent or balloon is already in the body for expansion.
  • the method according to the invention represents a transcatheter aortic valve implantation method (TAVI method or transcatheter aortic valve replacement, TAVR method) for a hybrid bioprosthesis.
  • the partial expansion of the first subregion of the at least second self-expanding partial implant is preferably triggered by a relative movement of the second insertion element with respect to the third insertion element of the insertion device, the relative movement being limited by means of a stop of the at least third insertion element.
  • a degree of movement of the second insertion element and thus the exposure of the self-expanding partial implant can be intuitively monitored and / or restricted structurally simple and intuitive for an operator.
  • the stepwise release of the self-expanding partial implant is easily accomplished.
  • the movement of the second insertion element takes place in particular in the direction of the proximal end of the insertion device.
  • the expansion aid with the first foreign expandable partial implant is partially positioned in the interaction region of the second self-expanding partial implant such that the first externally expandable partial implant is positioned distally of a valve plane of the second self-expanding partial implant.
  • a position control and / or a functional check of the flap can be carried out. If a faulty position of the first section is detected or the flap is insufficient, a repositioning step can now be performed.
  • a resheathing is performed first.
  • the at least second insertion element is pushed by a relative movement with respect to the first insertion of the insertion device again over the first portion of the second self-expanding partial implant, whereby this is pressed back to its original position.
  • the movement of the second insertion element takes place in particular in the direction of the distal end of the insertion device.
  • the first portion can be positioned by retracting the second insertion element again.
  • the expansion of the first externally expandable partial implant is performed by means of at least one expansion aid, such as a balloon, whereby the first portion of the second self-expanding partial implant is secured to an implantation site via an interaction region of the first externally expandable partial implant.
  • the first portion of the second self-expanding partial implant is also the interaction area of this partial implant.
  • the partial expansion of the second portion of the at least second self-expanding partial implant is triggered by a relative movement of the second insertion element with respect to the third insertion element of the insertion device, whereby the hybrid implant is completely released.
  • the hybrid implant is fully implanted using a fast and low-risk procedure.
  • the movement of the second insertion element takes place in particular in the direction of the proximal end of the insertion device.
  • Fig. 1 shows a longitudinal section through a favorable embodiment of an insertion device 10.
  • the insertion device 10 is used to insert a medical hybrid implant 100 with two partial implants 102, 104 and is for example a catheter having a shaft portion 36 with four coaxially arranged insertion elements 12, 14, 16, 18, for example a Balloon inner shaft (fourth introducer 18), a balloon outer shaft (first introducer 12), a catheter introducer (third introducer 16) and a catheter outer shaft (second introducer 14).
  • the second insertion element 14 lies radially outermost and thus surrounds the other three insertion elements 12, 16, 18.
  • the third insertion element 16 is thus radially between the first insertion element 12 and the second insertion element 14 and the fourth insertion element 18 arranged radially within the first insertion element 12.
  • a guide element 22 is received in the fourth insertion element 18.
  • This guide element 22 is a so-called "guide wire", at the distal end 34-22 of which a catheter tip 38 is arranged.
  • the guide element 22 is in parts in Fig. 1 schematically indicated by dashed line.
  • the second, outermost, insertion element 14 is in turn surrounded by a shaft jacket or a stabilizing tube 40.
  • the first insertion member 12 includes an expansion aid 20, in the form of a balloon, for expanding the first foreign expandable partial implant 102, wherein the expansion aid 20 is disposed at a distal end 42-12 of the first insertion member 12.
  • the second insertion element 14 is used to release the second self-expanding partial implant 104. This is done by a relative movement in the axial direction 58 between the second insertion member 14 and the third insertion member 16.
  • the insertion device 10 is in user operation, ie during attachment of the hybrid implant 100 or during implantation with its proximal end 44 facing a user.
  • the hybrid implant 100 is placed at a distal end 42-36 of the shaft portion 36 facing away from the user, for example near the catheter tip 38, between the balloon inner shaft and the catheter outer shaft and is intended to be located at the Implantation be released in the animal or human body (see. Fig. 5 to 12 ).
  • the hybrid implant 100 has two partial implants 102, 104, which in the Fig. 2 and 4 each shown individually.
  • the first partial implant 102 is designed to be expandable externally and is designated in the following text as a foreign expandable partial implant 102 (cf. Fig. 2 ).
  • the externally expandable partial implant 102 has a homogeneously executed skeleton 122 with a multiplicity of cells 114, 114 '.
  • the cells 114, 114 ' are uniformly diamond-shaped and extend circumferentially 124 side by side around a circumference of the externally expandable partial implant 102.
  • the externally expandable partial implant 102 is made of, for example, medical grade stainless steel or a Co-Cr alloy.
  • the externally expandable partial implant 102 is crimped onto the expansion aid 20 of the introducer 10. In this case, for example, a French size of 15 F or even 12 F can be achieved.
  • the externally expandable partial implant 102 may have a sealing structure 116. This is designed to reduce one, in particular valvular and / or paravalvular, leakage in the implanted state.
  • the sealing structure 116 promotes ingrowth of the hybrid implant 100 at the site of implantation, such as an aortic annulus (not shown). In the implanted state of the externally expandable partial implant 102, this is arranged such that the sealing structure 116 faces a flap insert 108 of the second self-expanding partial implant 104 (see below).
  • the sealing structure 116 may be formed, for example, by a so-called "textile skirt" and is made, for example, from a polyester such as Dacron®.
  • the second partial implant 104 is designed to be self-expanding and is referred to in the following text as a self-expanding partial implant 104 (cf. Fig. 4 ).
  • the self-expanding partial implant 104 is made of a shape memory material such as nitinol.
  • the self-expanding partial implant 104 has a skeleton 122 with a number of cells 114, 114 ', which is selected such that the second self-expanding partial implant 104 has a low radial force, thereby it can be compressed again if necessary with little effort.
  • the cells 114, 114 ' are substantially diamond-shaped and adjacent to each other in the circumferential direction 124, each offset in height alternately.
  • the second self-expanding partial implant 104 has the valve insert 108, for example, in the form of a porcine pericardium artificial aortic valve.
  • the self-expanding partial implant 104 is attached to an implant holder 46 located at a distal end 42-16 of the third introducer member 16.
  • the implant holder 46 for example, hooks not shown in detail, in which engage the eyelets 126 of the self-expanding partial implant 104 (not shown in detail).
  • the third insertion element 16 is designed to hold it in position during expansion of the second self-expanding partial implant 104.
  • the self-expanding partial implant 104 is covered with a protective sheath 48.
  • This protective sheath 48 is arranged or formed on a distal end 42-14 of the second insertion element 14.
  • the protective sheath 48 has, for example, an inner diameter (ID) of approximately 4.2 mm and an outer diameter (OD) of approximately 5.0 mm and thus a French size of 15 F. In general, these dimensions are determined by the hybrid implant 100 or flap insert 108 used. Covering takes place by a movement of the second insertion element 14 in the direction of the distal end 34 of the insertion device 10.
  • Both partial implants 102, 104 have interaction areas 106, 112 which are designed such that the two partial implants 102, 104 can interact with one another.
  • the interaction region 106 of the externally expandable partial implant 102 is described in US Pat Expansions Anlagen 20 mounted state of the externally expandable partial implant 102 whose proximal end portion 128 which faces the proximal end 44 of the introducer 10.
  • the sealing structure 116 is also arranged.
  • its interaction region 112 in the state mounted in the protective sheath 48 is located at a distal end region 118 of the self-expanding partial implant 104 facing the distal end 34 of the introducer 10.
  • the interaction region 112 is axially opposite the end region 120 with de Befest onlysmaschine 126th
  • FIG. 1 shows, each of the insertion elements 12, 14, 16, 18 and the stabilizing tube 40 on a handle segment 24, 26, 28, 30, 50, which is respectively adapted to the respective insertion element 12, 14, 16, 18 and the stabilizing tube 40th to move.
  • the grip segments 26, 28, 30, 50 of the insertion elements 14, 16, 18 and the stabilizing tube 40 are each designed as extending substantially perpendicular to a longitudinal axis of the proximal portion of the insertion device 10 handles.
  • the grip segments 26, 28, 30, 50 are each equipped with a Luer lock for venting the respective insertion element 14, 16, 18 or the stabilization tube 40 (not shown).
  • the handle segment 26 is releasable with the insertion element 16 or with the handle segment 28 and the handle segment 28 is detachably connected to the insertion element 12 (not shown in detail).
  • the grip segment 50 serves for fixing the stabilization hose 40.
  • the grip segment 24 of the first insertion element 12 is formed by a switch 52 for inflation or deflation of the expansion aid 20 (see below).
  • the handle segments 24, 30 are permanently connected to one another, whereby the insertion elements 12, 18 can be moved together both with the handle segment 24 and with the handle segment 30. All handle segments 24, 26, 28, 30, 50 are each at a proximal end 54-12, 54-14, 54-16, 54-18, 54-40 of the respective insertion member 12, 14, 16, 18 and the Stabilization hose 40 is arranged.
  • the proximal shaft portions of the insertion members 12, 14, 16, 18 can also be used as a handle segment.
  • the at least third insertion element 16 also has a stop 32, which limits a relative movement of the second insertion element 14 with respect to the third insertion element 16.
  • This stop 32 is formed, for example, by a mark.
  • the first foreign expandable partial implant 102 faces the distal end 34 of the introducer 10 and the second self-expanding partial implant 104 faces away from the distal end 34 of the introducer 10.
  • the externally expandable partial implant 102 is located distally of the self-expanding partial implant 104.
  • the interaction area 106, 112 thus face each other.
  • the following is a method for inserting a medical hybrid implant 100 by means of the insertion device 10 on the basis of Fig. 5 to 10 and the block diagrams of Fig. 11 and 12 described.
  • the two partial implants 102, 104 are as described above and in FIG Fig. 5 is shown mounted in / on the insertion device 10 (see Fig. 5 ).
  • the native aortic valve Prior to insertion of the introducer 10, the native aortic valve is pre-stretched in step 200 with a so-called valvuloplasty balloon. If the guide element 22 has not yet been placed in the insertion device 10, it will now be pushed over the guide element 22 in step 202. Subsequently, the thus prepared introducer 10 is inserted into the body for implantation of the hybrid implant 100 in the body in a known manner and positioned in step 204. Here, a flap plane 110 of the valve insert 108 should be flush with the annulus of the natural valve (not shown).
  • a first partial region 118 or the distal end region 118 of the self-expanding partial implant 104 exposed, causing it to expand automatically (see. Fig. 6 ).
  • the second insertion element 14 with the handle segment 26 in the direction of the proximal end 44 of the insertion device 10 is pulled (see arrow), whereby the second insertion member 14 is a relative movement in the axial direction 58 with respect to the other three insertion elements 12, 16, 18 completes.
  • the partial expansion of the first subregion 118 is thus triggered by a relative movement of the second insertion element 14 with respect to the third insertion element 16.
  • the pulling movement takes place in this case until a proximal end 54-26 of the handle segment 26 of the second insertion element 14 is at an axial height of the stop 32 of the third insertion element 16 (see the axial heights of the handle segment 26 of FIG Fig. 5 and 6 ).
  • the relative movement is limited by means of the stop 32 (see Fig. 6 ).
  • the self-expanding partial implant 104 is partially exposed, and the interaction region 112 has assumed an inner diameter D i in its expanded state, dimensioned to a dimension of an outer diameter D a of the interaction region 106 of the first foreign expandable partial implant 102 in its expanded state.
  • the inner diameter D i of the self-expanding partial implant 104 is minimally larger than the outer diameter D a of the externally expandable partial implant 102 so that it can enter the inner diameter D i of the self-expanding partial implant 104 (see below).
  • a position control of the expanded subarea 118 may be performed. Additionally, functional tests of the hybrid implant 100 or valve cartridge 108 may now be performed in step 210. If a misposition of the first portion 118 is detected or the flap insert 108 is insufficient, repositioning may now be performed in step 212.
  • a resheathing is performed first. In this case, the second insertion element 14 is pushed by a relative movement in the axial direction 58 with respect to the third insertion element 16 again over the first portion 118 of the second self-expanding partial implant 104, whereby this in his Home position is pressed back. The movement of the second insertion element 14 takes place in the direction of the distal end 34 of the insertion device 10.
  • the first portion 118 can be repositioned by retracting the second insertion element 14 again. If a malfunction is detected, the hybrid implant 100 may be removed from the body again. Since step 112 represents an alternative process step, it is in Fig. 11 shown as a box with dashed border. If a correct position has been reached, the second insertion element 14 is fixed in step 214 fixing proximally or again with the grip segment 26 on the third insertion element 16 or on the grip segment 28.
  • the externally expandable partial implant 102 and the expansion aid 20 are now positioned.
  • the interaction region 106 of the externally expandable partial implant 102 enters into the inner diameter D i of the interaction region 112 of the self-expanding partial implant 104.
  • this is only so far that the interaction region 106 is located distally of the valve plane 110 of the valve insert 108, thereby avoiding damaging the valve insert 108 (see FIG Fig. 7 in which the flap plane 110 is indicated only schematically by a dashed line).
  • the retraction takes place after a release of the connection between the handle segment 28 and the insertion element 12 by moving the first insertion element 12 by pulling on the handle segment 30 together with the fourth insertion element 18 in the direction of the proximal end 44 of the insertion device 10 (see arrow).
  • the first and the fourth insertion element 12, 18 can also be moved by pulling on the grip segment 24 or the switch 52.
  • the first insertion element 12 and the fourth insertion element 18 perform a relative movement in the axial direction 58 with respect to the second and third insertion elements 14, 16.
  • the first insertion element 12 is arranged displaceably within the second insertion element 14.
  • an axial distance between the handle segment 26 and the handle segment 28 is greater than shown here, so that a movement of the handle segment 26 in the direction of the proximal end 44 of the insertion device 10 for complete release of the second partial implant 104 is further possible (see below).
  • the first insertion element 12 is fixed proximally in step 114 'fixation.
  • the correct positions of the expanded distal portion 118 of the self-expanding partial implant 104 and that of the externally expandable partial implant 102 are checked again in step 208.
  • the function of the flap insert 108 should be checked again here in step 210 testing.
  • the complete first externally expandable partial implant 102 is released (see Fig. 8 ).
  • the expansion is carried out here by means of the expansion aid 20.
  • a medium not shown in detail, such as compressed air or saline solution, supplied via the switch 52 (see arrow), wherein the first insertion element 12 for this purpose has a feed channel not shown in detail.
  • the interaction region 106 of the externally expandable partial implant 102 has now assumed, in the expanded state, an outer diameter D a which is matched to the inner diameter D i of the interaction region 112 of the self-expanding partial implant 104 (for better visualization, the same extension is used for both diameters shown, although the outer diameter D a is minimally greater than the inner diameter D i ).
  • expansion of the externally expandable partial implant 102 secures the first portion 118 of the second self-expanding partial implant 104 to a destination or implantation site (not shown in detail) via the interaction portion 106 of the first foreign expandable partial implant 102.
  • step 220 emptying, the medium is now removed from the expansion aid 20 (see arrow), whereby it deflates.
  • the externally expandable partial implant 102 and thereby also the partial region 118 of the self-expanding partial implant 104 remain in their expanded state at the implantation site (see Fig. 9 ).
  • step 208 verification of the correct positions of the expanded distal portion 118 of the self-expanding partial implant 104 and that of the foreign expandable partial implant 102 is performed.
  • step 222 the self-expanding partial implant 104 is disengaged from the implant holder 46. This is accomplished, for example, by radially retracting the hooks of the implant holder 46 from the attachment loops 126 of the proximal end portion 120 of the self-expanding partial implant 104 (not shown in detail).
  • a second partial region 120 or the proximal end region 120 of the second self-expanding partial implant 104 is exposed, as a result of which it automatically expands (cf. Fig. 10 ).
  • the second insertion element 14 with the handle segment 26 after releasing the fixation again in the direction of the proximal end 44 of the insertion device 10 is pulled (see arrow), whereby the second insertion member 14 is a relative movement in the axial direction 58 with respect to the other three insertion elements 12, 16th , 18 completes.
  • the partial expansion of the second subregion 120 is thus triggered by a relative movement of the second insertion element 14 with respect to the third insertion element 16. The pulling movement takes place until the hybrid implant 100 is completely released.
  • step 226 the protective sheath 48 is closed, and subsequently, in step 228, the introducer 10 is withdrawn and removed from the body.
  • the hybrid implant 100 remains fully positioned in the body (not shown).
  • an aortogram is ultimately acquired in step 230.
  • one of the components / component of the introducer 10 or the hybrid implant 100 can also be formed from a radiopaque metal, such as stainless steel, tantalum, gold or platinum.
  • a radiopaque metal such as stainless steel, tantalum, gold or platinum.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Prostheses (AREA)
EP14158463.1A 2013-04-11 2014-03-10 Dispositif d'introduction, notamment cathéter, pour l'introduction d'un implant hybride médical et implant hybride médical destiné à être introduit à l'aide d'un dispositif d'introduction Withdrawn EP2789313A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361810719P 2013-04-11 2013-04-11

Publications (2)

Publication Number Publication Date
EP2789313A2 true EP2789313A2 (fr) 2014-10-15
EP2789313A3 EP2789313A3 (fr) 2015-01-28

Family

ID=50238233

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14158463.1A Withdrawn EP2789313A3 (fr) 2013-04-11 2014-03-10 Dispositif d'introduction, notamment cathéter, pour l'introduction d'un implant hybride médical et implant hybride médical destiné à être introduit à l'aide d'un dispositif d'introduction

Country Status (2)

Country Link
US (1) US20140309680A1 (fr)
EP (1) EP2789313A3 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767264B1 (fr) * 2013-02-13 2017-08-23 Biotronik AG Dispositif de recouvrement destiné à recouvrir un implant médical au moins partiellement découvert, dans un cathéter, cathéter doté d'un dispositif de recouvrement
EP3295898A1 (fr) 2016-09-20 2018-03-21 Biotronik AG Implant hybride medical destine a etancheifier des fuites paravalvulaires

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10034747B2 (en) 2015-08-27 2018-07-31 Medtronic Vascular, Inc. Prosthetic valve system having a docking component and a prosthetic valve component
US10357363B2 (en) * 2016-06-09 2019-07-23 Medtronic Vascular, Inc. Transcatheter valve delivery system with crimped prosthetic heart valve
US10588745B2 (en) 2016-06-20 2020-03-17 Medtronic Vascular, Inc. Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis
CN107550524B (zh) * 2016-07-01 2020-01-03 先健科技(深圳)有限公司 输送装置
US10842624B2 (en) * 2017-03-10 2020-11-24 St. Jude Medical, Cardiology Division, Inc. Transseptal mitral valve delivery system
CN113164254B (zh) * 2018-10-30 2024-02-06 爱德华兹生命科学公司 人工瓣膜递送组件
US11707355B2 (en) 2020-05-28 2023-07-25 Medtronic, Inc. Modular heart valve prosthesis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166636A1 (en) 2007-02-27 2011-07-07 Edwards Lifesciences Corporation Method and Apparatus for Replacing a Prosthetic Valve

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060217802A1 (en) * 2004-12-16 2006-09-28 Carlos Ruiz Heart valve and method for insertion of the heart valve into a bodily vessel
US20110077731A1 (en) * 2009-09-25 2011-03-31 Abbott Cardiovascular Systems Inc. Multiple stent delivery system
EP2595569B1 (fr) * 2010-07-23 2024-12-18 Edwards Lifesciences Corporation Mécanismes de rétention pour prothèses valvulaires

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166636A1 (en) 2007-02-27 2011-07-07 Edwards Lifesciences Corporation Method and Apparatus for Replacing a Prosthetic Valve

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767264B1 (fr) * 2013-02-13 2017-08-23 Biotronik AG Dispositif de recouvrement destiné à recouvrir un implant médical au moins partiellement découvert, dans un cathéter, cathéter doté d'un dispositif de recouvrement
EP3295898A1 (fr) 2016-09-20 2018-03-21 Biotronik AG Implant hybride medical destine a etancheifier des fuites paravalvulaires

Also Published As

Publication number Publication date
EP2789313A3 (fr) 2015-01-28
US20140309680A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
EP2789313A2 (fr) Dispositif d'introduction, notamment cathéter, pour l'introduction d'un implant hybride médical et implant hybride médical destiné à être introduit à l'aide d'un dispositif d'introduction
EP1942834B1 (fr) Instrument médical auto-extensible pour le traitement de défaillances cardiaques chez un patient
EP2422748B1 (fr) Implant médical, notamment implant à clapet pour l'implantation dans un corps animal et/ou humain et procédé, notamment procédé de fabrication, pour la fabrication d'un dispositif d'implantation pour l'implant médical
DE10049814B4 (de) Vorrichtung zur Unterstützung chirurgischer Maßnahmen innerhalb eines Gefäßes, insbesondere zur minimalinvasiven Explantation und Implantation von Herzklappen
EP3863567B1 (fr) Implant pour le traitement et/ou pour le remplacement d'une valve cardiaque touchée par une inflammation, une thrombose ou une dégénérescence
DE60309843T2 (de) Vorrichtung zur verankerung von endoluminalprothesen
EP3897454B1 (fr) Dispositif pour introduire et mettre en place un implant dans un vaisseau sanguin
EP1940321B1 (fr) Dispositif pour implanter et fixer des valvules prothetiques
EP2786726B1 (fr) Cathéter pour l'implantation trans-vasculaire de prothèses de valvules cardiaques
DE69732411T2 (de) Reparieren von Körpergefäßen durch Prothesen
DE69629871T2 (de) Prothetisches Implantat
EP3169276B1 (fr) Prothèse de valvule cardiaque permettant le remplacement percutané de la valvule tricuspide et système comportant une telle prothèse de valvule cardiaque
DE10334868B4 (de) Implantierbare Einrichtung als Organklappenersatz, dessen Herstellungsverfahren sowie Grundkörper und Membranelement dafür
DE202017104793U1 (de) Ladesystem für Herzklappenprothesen
EP3154474B1 (fr) Prothèse de valvule cardiaque pour le remplacement percutané de la valvule tricuspide, ensemble et système comportant une telle prothèse de valvule cardiaque
DE112013004988T5 (de) Behandlungsvorrichtung einer Blutbahn
EP2710985A2 (fr) Implant, système constitué d'un implant et d'un cathéter et procédé de fabrication d'un tel système
DE202013011734U1 (de) Katheter-Zuführsystem zum Einführen einer expandierbaren Herzklappenprothese sowie medizinische Vorrichtung zum Behandeln eines Herzklappendefekts
WO2014026870A2 (fr) Dispositif implantable destiné à être utilisé dans un corps humain et/ou animal pour remplacer un clapet organique
DE202007005491U1 (de) Medizinische Vorrichtung zur Behandlung einer Aortenklappeninsuffizienz
DE202008018557U1 (de) Eine Ersatzklappe
EP2918249A2 (fr) Système de cathéter supra-claviculaire pour un accès transseptal à l'oreillette gauche et ventricule gauche
DE102015111783A1 (de) Kathetersystem zur Lokalisierung und Implantation eines Körperteilersatzes
EP3231393B1 (fr) Valve tricuspide et mitrale implantable a invasion minimale
DE102004062296A1 (de) Vorrichtung zum Positionieren eines Stents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140310

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 2/24 20060101AFI20141222BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150729